Quick Listen: Scrip’s Five Must-Know Things
In this week's episode: China deal controls a hot BIO topic; pharma eyes $2 trillion in sales; Apogee helps AbbVie achieve vision; Sangamo files for bankruptcy; and a review of Weber’s time at Takeda.
Scrip - June 29, 2026

Geneoscopy RNA-Based Colorectal Cancer Test Now Available Nationwide Through Labcorp
Labcorp has announced the availability of the ColoSense colorectal screening test across the US. The announcement marks the first FDA-approved at-home test that uses RNA technology to detect biomarkers associated with both colorectal cancer and precancerous changes that may point to disease.
Medtech Insight - June 26, 2026

Siemens Healthineers Awarded $6.9M Contract With ARPA-H Cybersecurity Initiative
Siemens Healthineers secured a $6.9m contract from ARPA-H to develop an AI-powered cybersecurity patching systems for two hospitals, addressing the growing vulnerability of health systems that are faced with unique challenges to thwart against cyber threats.
Medtech Insight - June 26, 2026

Signos Study: Engagement With AI Metabolic App Nearly Triples Weekly Weight Loss Rate
Adults with obesity who actively used a CGM-integrated AI coaching platform lost weight nearly three times faster than during disengaged periods, a 3,007-participant retrospective study shows — with consistent results across obesity classes, sexes, and age groups regardless of when engagement began.
Medtech Insight - June 26, 2026

TISSIUM’s Sutureless Surgery Bet Clears FDA But Needs To Win With Surgeons
Backed by €60m and an FDA authorization, TISSIUM is rolling out a sutureless repair system for peripheral nerve repair – and testing whether surgeons will trade thread for light.
Medtech Insight - June 26, 2026

Recertifications And AI High On EU Parliament’s MDR/IVDR Negotiation Priorities
EU co-legislator negotiations on the European Commission’s targeted amendments to the MDR and IVDR reached their first major stage this week when the European Parliament’s IMCO committee presented its draft opinion.
Medtech Insight - June 26, 2026

Korean Pilot Project Lets Hospitals Securely Share Data For AI Training
Consortium of 48 organizations, including hospitals and tech firms, will collaborate on federated space for sharing medical records without exporting data.
Medtech Insight - June 26, 2026

HistoSonics Lifts Valuation To $3.75bn, Eyes Kidney De Novo Decision
With backing from Reed Jobs and Yosemite, HistoSonics’ $3.75bn valuation comes as the company pursues kidney and pancreatic tumor indications alongside expanding liver-tumor adoption.
Medtech Insight - June 26, 2026

Kimberly-Clark Forecasts Kenvue Tailwinds: Brands ‘Early In Journey,’ Market of ‘Aging Population’
Kenvue’s product categories “still have a huge opportunity to be further developed through communications and marketing and partnership with retailers” while the “combination of our engineers and their scientists” will be a strength,” says Kimberly-Clark CEO Mike Hsu.
HBW Insight - June 28, 2026

US Approves First Rifapentine Generic
The US FDA has approved the first generic version of rifapentine (Priftin) 28–years after Sanofi’s approval, expanding patient access to TB treatment.
Generics Bulletin - June 26, 2026

Regulatory Recap: US Senate Committee Passes Two Off-Patent Bills But Delays Generics Access Act
Generics Bulletin reviews global regulatory developments across the world.
Generics Bulletin - June 26, 2026

Tanvex Hits Strike Three On US Trastuzumab Biosimilar
Tanvex’s US trastuzumab biosimilar TX05 has drawn a third FDA complete response letter, with the latest setback again tied to its third-party downstream manufacturer rather than the biosimilar’s drug substance.
Generics Bulletin - June 26, 2026

Automating Clinical Decisions For Healthcare System Efficiencies
AI-enabled workflow-centric approaches are gaining currency as health systems and life science innovators see potential to slash administrative bloat, accelerate clinical trials and optimize clinical operations. But there remains a chasm between AI healthcare promises and clinical reality.
In Vivo - June 26, 2026